Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Female pattern hair loss does not significantly affect sexual dysfunction.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Some medications can help increase sexual desire and function in women.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

5α-Reductase inhibitors can negatively impact sexual function.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

New genes and pathways are important for testosterone production and male sexual development.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

A female dog with mixed male and female traits was treated successfully with surgery.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Addressing body image and weight can help improve female sexual dysfunction.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

Women have smaller foreheads and different hairline shapes than men.

Serenoa repens may cause long-lasting sexual and psychiatric side effects.